Active Psoriatic Arthritis Yields to Stelara (CME/CE)

(MedPage Today) -- Patients with active psoriatic arthritis -- even those who had previously received a tumor necrosis factor (TNF) inhibitor -- experienced significant benefits with ustekinumab (Stelara) in a multicenter phase III trial.
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news